EC pledges €4.9bn to grant access to medicines

Under the Coronavirus Global Response Framework, the European Commission is allocating further €4.9bn to assure access to COVID-19 countermeasures for poor countries.

Read more

LSP leads €11m Series A round in OneProject

OneProjects Ltd, an Irish-German cardiac imaging specialist, has closed an €11m Series A financing led by Amsterdam-headquartered life sciences investor LSP.

Read more

Illumina and Epidarex Capital invest in post-Brexit UK

Illumina has opened its first accelerator outside the US in Cambridge to fund genomics start-ups. Meanwhile, Epidarex Capital has raised £102m for UK biotechs.

Read more

Novel adjuvant teases T cells to respond to HCV

Researchers from Italy, Denmark and the UK have devised a new vaccination strategy to tackle hepatitis C and boosting the required strong T cell response.

Read more

First drug found to reduce COVID-19-mortality

A clinical trial has identified the first immuno-modulatory drug to significantly reduce COVID-19 mortality in ventilated patients.

Read more

Germany puts €300m in CureVac AG for COVID-19 vaccine

In the race aimed at securing access to COVID-19 vaccines, Germany has acquired a minority stake in the local mRNA vaccine producer Curevac AG.

Read more

Abbvie and Genmab team up in oncology

AbbVie is partnering with Genmab A/S to commercialise up to seven new antibody formats.

Read more

Evox Therapeutics signs US$1.2bn deal with Eli Lilly

Evox Therapeutics Ltd has licenced its exosome-based RNAi/antisense RNA delivery technology to Eli Lilly to target selected neurological diseases. 

Read more

Calliditas Therapeutics raise US$90m in Nasdaq IPO

Swedish budenoside formulation specialist Calliditas Therapeutics  AB has successfully raised US$90m in an oversubscribed NASDAQ IPO.

Read more